1 Tan Y, Ichikawa T, Li J, Si Q, Yang H, Chen X, Goldblatt CS, Meyer CJ, Li X, Cai L, Cui T. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 2011 Feb;60(2):625-33. doi: 10.2337/db10-1164. PMID: 21270272; PMCID: PMC3028364.
2 Kanellakis S, Mavrogianni C, Karatzi K, Lindstrom J, Cardon G, Iotova V, Wikström K, Shadid S, Moreno LA, Tsochev K, Bíró É, Dimova R, Antal E, Liatis S, Makrilakis K, Manios Y. Development and Validation of Two Self-Reported Tools for Insulin Resistance and Hypertension Risk Assessment in A European Cohort: The Feel4Diabetes-Study. Nutrients. 2020 Mar 30;12(4):960. doi: 10.3390/nu12040960. PMID: 32235566; PMCID: PMC7230581.
3 Wiebe N, Stenvinkel P, Tonelli M. Associations of Chronic Inflammation, Insulin Resistance, and Severe Obesity With Mortality, Myocardial Infarction, Cancer, and Chronic Pulmonary Disease. JAMA Netw Open. 2019;2(8):e1910456. doi:10.1001/jamanetworkopen.2019.10456
4 Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, Oudit GY, Lopaschuk GD. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovasc Diabetol. 2019 Jul 5;18(1):86. doi: 10.1186/s12933-019-0892-3. PMID: 31277657; PMCID: PMC6610921.
5 Han T, Lan L, Qu R, Xu Q, Jiang R, Na L, Sun C. Temporal Relationship Between Hyperuricemia and Insulin Resistance and Its Impact on Future Risk of Hypertension. Hypertension. 2017 Oct;70(4):703-711. doi: 10.1161/HYPERTENSIONAHA.117.09508. Epub 2017 Aug 14. PMID: 28808071.
6 Zhi L, Yuzhang Z, Tianliang H, Hisatome I, Yamamoto T, Jidong C. High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo. PLoS One. 2016 Feb 2;11(2):e0147737. doi: 10.1371/journal.pone.0147737. PMID: 26836389; PMCID: PMC4737875.
7 Su M, Sun L, Li W, Liu H, Liu Y, Wei Y, Yuan Y, Zheng L, Yin S, Dai C, Zhao C, Pan Z, Li Y. Metformin alleviates hyperuricaemia-induced serum FFA elevation and insulin resistance by inhibiting adipocyte hypertrophy and reversing suppressed white adipose tissue beiging. Clin Sci (Lond). 2020 Jun 26;134(12):1537-1553. doi: 10.1042/CS20200580. PMID: 32556103.
8 Zhu Y, Hu Y, Huang T, Zhang Y, Li Z, Luo C, Luo Y, Yuan H, Hisatome I, Yamamoto T, Cheng J. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014 May 16;447(4):707-14. doi: 10.1016/j.bbrc.2014.04.080. Epub 2014 Apr 21. PMID: 24769205.
9 Yuan H, Hu Y, Zhu Y, Zhang Y, Luo C, Li Z, Wen T, Zhuang W, Zou J, Hong L, Zhang X, Hisatome I, Yamamoto T, Cheng J. Metformin ameliorates high uric acid-induced insulin resistance in skeletal muscle cells. Mol Cell Endocrinol. 2017 Mar 5;443:138-145. doi: 10.1016/j.mce.2016.12.025. Epub 2016 Dec 30. PMID: 28042024.
10 Toyama EQ, Herzig S, Courchet J, Lewis TL Jr, Losón OC, Hellberg K, Young NP, Chen H, Polleux F, Chan DC, Shaw RJ. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science. 2016 Jan 15;351(6270):275-281. doi: 10.1126/science.aab4138. PMID: 26816379; PMCID: PMC4852862.
11 Hua J, Liu Z, Liu Z, An D, Lai W, Zhan Q, Zeng Q, Ren H, Xu D. Metformin Increases Cardiac Rupture After Myocardial Infarction via the AMPK-MTOR/PGC-1α Signaling Pathway in Rats with Acute Myocardial Infarction. Med Sci Monit. 2018 Oct 2;24:6989-7000. doi: 10.12659/MSM.910930. PMID: 30275441; PMCID: PMC6180847.
12 Zhang Y, Yamamoto T, Hisatome I, Li Y, Cheng W, Sun N, Cai B, Huang T, Zhu Y, Li Z, Jing X, Zhou R, Cheng J. Uric acid induces oxidative stress and growth inhibition by activating adenosine monophosphate-activated protein kinase and extracellular signal-regulated kinase signal pathways in pancreatic β cells. Mol Cell Endocrinol. 2013 Aug 15;375(1-2):89-96. doi: 10.1016/j.mce.2013.04.027. Epub 2013 May 23. PMID: 23707617.
13 Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, Prifti E, Vieira-Silva S, Gudmundsdottir V, Pedersen HK, Arumugam M, Kristiansen K, Voigt AY, Vestergaard H, Hercog R, Costea PI, Kultima JR, Li J, Jørgensen T, Levenez F, Dore J; MetaHIT consortium, Nielsen HB, Brunak S, Raes J, Hansen T, Wang J, Ehrlich SD, Bork P, Pedersen O. Corrigendum: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2017 May 3;545(7652):116. doi: 10.1038/nature22318. Erratum for: Nature. 2015 Dec 10;528(7581):262-266. PMID: 28470190.
14 Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation. 2009 May 19;119(19):2568-77. doi: 10.1161/CIRCULATIONAHA.108.798561. Epub 2009 May 4. PMID: 19414638.
15 Yue R, Hu H, Yiu KH, Luo T, Zhou Z, Xu L, Zhang S, Li K, Yu Z. Lycopene protects against hypoxia/reoxygenation-induced apoptosis by preventing mitochondrial dysfunction in primary neonatal mouse cardiomyocytes. PLoS One. 2012;7(11):e50778. doi: 10.1371/journal.pone.0050778. Epub 2012 Nov 30. PMID: 23226382; PMCID: PMC3511264.
16 Wang C, Liu N, Luan R, Li Y, Wang D, Zou W, Xing Y, Tao L, Cao F, Wang H. Apelin protects sarcoplasmic reticulum function and cardiac performance in ischaemia-reperfusion by attenuating oxidation of sarcoplasmic reticulum Ca2+-ATPase and ryanodine receptor. Cardiovasc Res. 2013 Oct 1;100(1):114-24. doi: 10.1093/cvr/cvt160. Epub 2013 Jun 13. PMID: 23771946.
17 Han X, Tao Y, Deng Y, Yu J, Sun Y, Jiang G. Metformin accelerates wound healing in type 2 diabetic db/db mice. Mol Med Rep. 2017 Dec;16(6):8691-8698. doi: 10.3892/mmr.2017.7707. Epub 2017 Oct 4. PMID: 28990070; PMCID: PMC5779947.
18 Li JM, Zhang X, Wang X, Xie YC, Kong LD. Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice. Eur J Pharmacol. 2011 Sep;666(1-3):196-204. doi: 10.1016/j.ejphar.2011.05.021. Epub 2011 May 23. PMID: 21620826.
19 Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006 Mar;290(3):F625-31. doi: 10.1152/ajprenal.00140.2005. Epub 2005 Oct 18. PMID: 16234313.
20 Tai S, Li X, Zhu Z, Tang L, Yang H, Fu L, Hu X, Fang Z, Zhou S. Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome. Cardiovasc Ther. 2020 Feb 22;2020:2615147. doi: 10.1155/2020/2615147. PMID: 32161625; PMCID: PMC7057023.
21 Huang WS, Lin CL, Tsai CH, Chang KH. Association of gout with CAD and effect of antigout therapy on CVD risk among gout patients. J Investig Med. 2020 Jun;68(5):972-979. doi: 10.1136/jim-2019-001140. Epub 2020 Feb 24. PMID: 32098832; PMCID: PMC7306869.
22 Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006 Aug;54(8):2688-96. doi: 10.1002/art.22014. PMID: 16871533.
23 Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003 Apr 22;107(15):1991-7. doi: 10.1161/01.CIR.0000065637.10517.A0. Epub 2003 Apr 21. PMID: 12707250.
24 Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, Leyva F, Proudler AJ, Coats AJ, Anker SD. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005 Sep 20;46(6):1019-26. doi: 10.1016/j.jacc.2005.02.093. PMID: 16168285.
25 Szabo T, von Haehling S, Habedank D, Rauchhaus M, Lainscak M, Sandek A, Schefold J, Anker SD, Doehner W. Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure. Int J Cardiol. 2011 Feb 17;147(1):47-51. doi: 10.1016/j.ijcard.2009.07.030. Epub 2009 Sep 5. PMID: 19733925.
26 Yang J, Holman GD. Long-term metformin treatment stimulates cardiomyocyte glucose transport through an AMP-activated protein kinase-dependent reduction in GLUT4 endocytosis. Endocrinology. 2006 Jun;147(6):2728-36. doi: 10.1210/en.2005-1433. Epub 2006 Mar 2. PMID: 16513829.
27 Vlavcheski F, Den Hartogh DJ, Giacca A, Tsiani E. Amelioration of High-Insulin-Induced Skeletal Muscle Cell Insulin Resistance by Resveratrol Is Linked to Activation of AMPK and Restoration of GLUT4 Translocation. Nutrients. 2020 Mar 27;12(4):914. doi: 10.3390/nu12040914. PMID: 32230718; PMCID: PMC7230755.
28 Zhang S, Zhou Y, Zhao L, Tian X, Jia M, Gu X, Feng N, An R, Yang L, Zheng G, Li J, Guo H, Fan R, Pei J. κ-opioid receptor activation protects against myocardial ischemia-reperfusion injury via AMPK/Akt/eNOS signaling activation. Eur J Pharmacol. 2018 Aug 15;833:100-108. doi: 10.1016/j.ejphar.2018.05.043. Epub 2018 May 30. PMID: 29856969.
29 Mangano DT. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group. JAMA. 1997;277(4):325-332. doi:10.1001/jama.277.4.325
30 Beker MC, Caglayan B, Caglayan AB, Kelestemur T, Yalcin E, Caglayan A, Kilic U, Baykal AT, Reiter RJ, Kilic E. Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival. Sci Rep. 2019 Dec 13;9(1):19082. doi: 10.1038/s41598-019-55663-0. PMID: 31836786; PMCID: PMC6910929.
31 Russell RR 3rd, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol. 1999 Aug;277(2):H643-9. doi: 10.1152/ajpheart.1999.277.2.H643. PMID: 10444490.